[1]
2024. Treatment Response to Sorafenib in Liver Cancer; A Comprehensive Review on Association with Single Nucleotide Polymorphisms. Precision Medicine Communications. 4, 2 (Dec. 2024), 85–114. DOI:https://doi.org/10.55627/pmc.004.002.0555.